The dosage market size value per capita for Penicillins and Streptomycins in Belgium experienced fluctuations from 2013 to 2023. The market stood at $11.17 in 2023. The year-on-year percentage variation reveals notable shifts, with a significant dip in 2022 followed by a slight rebound in 2023. Over the last five years, the compound annual growth rate (CAGR) indicates a modest upward trend, reflecting resilience despite periodic downturns.
Future trends to watch include potential impacts of new healthcare policies and antibiotic resistance issues, influencing market dynamics. Innovations in pharmaceutical research and changes in prescribing practices could also shape future market movements.
